Long-term L-3-n-butylphthalide pretreatment attenuates ischemic brain injury in mice with permanent distal middle cerebral artery occlusion through the Nrf2 pathway
L-3-n-butylphthalide (NBP), which is used for treatment of mild and moderate acute ischemic stroke, exerts its effects by modulating the Nrf2 pathway. However, it has not been established whether NBP exerts its preventive effects in high-risk ischemic stroke patients through the Nrf2 pathway. We inv...
Main Authors: | Mingying Sun, Changchun Jiang, Xiwa Hao, Jiangxia Pang, Chao Chen, Wenping Xiang, Jun Zhang, Shijun Zhao, Po Wang, Shangyong Geng, Hanzhang Wang, Yuechun Li, Baojun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022011975 |
Similar Items
-
Corrigendum to “Long-term L-3-n-butylphthalide pretreatment attenuates ischemic brain injury in mice with permanent distal middle cerebral artery occlusion through the Nrf2 pathway” [Heliyon 8 (7), (July 2022), Article e09909]
by: Mingying Sun, et al.
Published: (2022-09-01) -
DL-3-n-butylphthalide attenuates doxorubicin-induced acute cardiotoxicity via Nrf2/HO-1 signaling pathway
by: Dengke Li, et al.
Published: (2024-03-01) -
The neuroprotective effect of Dl-3-n-butylphthalide in epileptic rats via inhibiting endoplasmic reticulum stress
by: Shuang Tian, et al.
Published: (2023-01-01) -
DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress
by: Hui Zhang, et al.
Published: (2023-01-01) -
Unveiling the potential of Butylphthalide: inhibiting osteoclastogenesis and preventing bone loss
by: Feng Yanbin, et al.
Published: (2024-02-01)